Holen Sie sich die Stockscreener-App
1.13
3.67%
0.04
Handel nachbörslich:
1.18
0.05
+4.42%
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Neuronetics to Unveil Q3 2024 Financial Results - MSN
Neuronetics extends Madryn registration rights period By Investing.com - Investing.com South Africa
Neuronetics extends Madryn registration rights period - Investing.com India
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - The Manila Times
Transcranial Magnetic Stimulator Market Projected To Witness Substantial Growth, 2024-2031:Nexstim Plc, - EIN News
Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com
NeuroStar TMS data presented at AACAP meeting By Investing.com - Investing.com Australia
NeuroStar TMS data presented at AACAP meeting - Investing.com
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - The Manila Times
Transcranial Magnetic Stimulator Market will generate new - openPR
Neuronetics executive sells shares worth over $1,200 By Investing.com - Investing.com South Africa
Neuronetics executive sells shares worth over $1,200 - Investing.com India
Neuronetics EVP Stephen Furlong sells shares worth over $1,100 - Investing.com India
Neuronetics faces potential Nasdaq delisting - Investing.com India
Neuronetics faces potential Nasdaq delisting By Investing.com - Investing.com UK
Neuronetics Moves to Acquire Greenbrook in Stock Deal - TipRanks
Neuronetics Set to Acquire Greenbrook TMS - TipRanks
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings - StockTitan
Neuronetics Outlines Greenbrook Acquisition Prospects and Risks - TipRanks
SEC Form DEFA14A filed by Neuronetics Inc. - Quantisnow
Neuronetics Expands TMS Access for Adolescents with Depression - MyChesCo
Neuronetics GAAP EPS of -$0.27 beats by $0.04, revenue of $17.42M beats by $0.3M - MSN
STIM stock rated a Mkt perform by William Blair - Knox Daily
Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook - Investing.com
In the Green: Neuronetics Inc (STIM) Closes at 0.75, Up/Down -3.85 from Previous Day - The Dwinnex
Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook By Investing.com - Investing.com South Africa
Neuronetics Inc (STIM) deserves closer scrutiny - US Post News
Neuronetics Inc [STIM] Shares Fall -6.18 % on Wednesday - Knox Daily
Neuronetics Inc (STIM) Stock: A Year of Declines and Increases - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for Neuronetics Inc (STIM) - The Dwinnex
Stoke Therapeutics Inc (STOK) expanding its growth trajectory ahead - SETE News
Neuronetics announces HCSC expanded access to TMS for adolescents - TipRanks
In the Green: NeuroSense Therapeutics Ltd (NRSN) Closes at 1.25, Up/Down -3.50 from Previous Day - The Dwinnex
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents - Yahoo Finance
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World
NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule - PR Newswire
How did Stoke Therapeutics Inc (STOK) fare last session? - US Post News
Logos Global Management LP Invests $14.19 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK) - MarketBeat
Recent Insider Activity Could Benefit Stoke Therapeutics Inc (STOK) - Knox Daily
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 4.7% - MarketBeat
STIM Stock Likely to Gain From Updated TMS Coverage - Zacks Investment Research
First Eagle Investment Management LLC Purchases 260,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo
Neuronetics Enhances NeuroStar Therapy with New Features - MSN
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults - StockTitan
Acadian Asset Management LLC Purchases 62,628 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Greenbrook TMS announces acquisition by Neuronetics - Investing.com Canada
STIM’s Stock Swings: Riding the 2023 Wave of Ups and Downs - The InvestChronicle
3.48%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):